Joann Huber

Statistics

Publications

Citations

468

H-Index

Active since

1995

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD (Spain)

Joann Huber is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in antibacterial pharmacology, drug discovery, and life sciences.

Publications per year

1995–2012

Publications

Chemical Genetic Identification of Peptidoglycan Inhibitors Potentiating Carbapenem Activity against Methicillin-Resistant Staphylococcus aureus

Joann Huber, Robert G. K. Donald, Sang Ho Lee et al. · Chemistry & Biology · 2009 · 115 citations

Life Sciences, Medicinal Chemistry, Pharmacology +16

Broadening the Spectrum of β-Lactam Antibiotics through Inhibition of Signal Peptidase Type I

Alex G. Therien, Joann Huber, Kenneth E. Wilson et al. · Antimicrobial Agents and Chemotherapy · 2012 · 78 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

Dicationic 2-fluorenonylcarbapenems: Potent anti-MRS agents with improved solubility and pharmacokinetic properties

Mark L. Greenlee, Joanne B. Laub, Gregory P. Rouen et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 61 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacokinetics +17

Inhibition of IMP-1 metallo-Î²-lactamase and sensitization of IMP-1-producing bacteria by thioester derivatives

Gail G. Hammond, Joann Huber, Mark L. Greenlee et al. · FEMS Microbiology Letters · 1999 · 49 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Reduced Immunotoxicity and Preservation of Antibacterial Activity in a Releasable Side-Chain Carbapenem Antibiotic

Hugh Rosen, Richard Hajdu, Lynn L. Silver et al. · Science · 1999 · 37 citations

Life Sciences, Immunology, Pharmacology +17

1–5 of 10